GP Indemnity: Corporate Finance and Non-Life Actuarial Advice

The Authority requires a third party corporate finance adviser to provide us with an actuarial analysis on each participating MDO's assets and liabilities, to provide input and advice into the commercial structuring of the Existing Liabilities Scheme (ELS) - considering the potential impact of regulation on the MDO's and how they may respond; and to assist with the MDO negotiation strategy and negotiations. We expect that the actuarial advice will be provided by the adviser themselves as opposed to using third party partner firms.

The project will cover:

Phase 1 - Pre-Due Diligence - regulation (January 2018)

Phase 2 - Actuarial Due Diligence on Medical Defence Organisation Balance Sheets (February 2018 to April 2018)

Phase 3 - Transaction Structuring (May 2018 - June 2018)

Phase 4 - Negotiation (July 2018 - September 2018)

Phase 5 - Commercial Due Diligence (October 2018 - November 2018)

This scope of works will provide appropriate expertise from a corporate finance adviser with internal actuarial expertise in support of the project's objectives. With the benefit of significant and detailed due diligence allowing us to obtain a full understanding of MDO's financial positions, we will be able to properly assess the level of assets that could be obtained versus the pace of regulation implementation. We need to ensure an appropriate balance which delivers value for money, does not contravene state aid principles and above all creates a safe, secure and affordable future operating environment for medical practitioners and patients.

Therefore the skills required to deliver these outputs are: -